Long-term, topical insulin administration increases the severity of retinal vascular pathology in streptozotocin-induced diabetic rats

Optometry

Volumn 78, Issue 11, 2007, Pages 574-581

  Koevary, Steven B ^a   Nussey, Jennifer ^a   Kern, Timothy S ^b  

^a NEW ENGLAND COLLEGE OF OPTOMETRY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Diabetic retinopathy; Insulin; Prevention; Rat; Topical

Indexed keywords

INSULIN;

ANIMAL; ARTICLE; DIABETIC RETINOPATHY; DRUG ADMINISTRATION; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HOSPITALIZATION; LEWIS RAT; PATHOLOGY; RAT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DRUG ADMINISTRATION SCHEDULE; FEMALE; INSULIN; RATS; RATS, INBRED LEW; SEVERITY OF ILLNESS INDEX;

EID: 35448954746     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2007.01.010     Document Type: Article

References (39)

1. Cogan D.G., Toussaint D., and Kuwabara T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66 (1961) 366-378
2. Kuwabara T., and Cogan D.G. Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69 (1963) 492-502
3. Addison D.J., Garner A., and Ashton N. Degeneration of intramural pericytes in diabetic retinopathy. Br Med J 1 (1970) 264-266
4. Engerman R.L. Pathogenesis of diabetic retinopathy. Diabetes 38 (1989) 1203-1206
5. Ashton N. Pathogenesis of diabetic retinopathy. In: Little H.L., Jack R.L., Patz A., et al. (Eds). Diabetic retinopathy (1983), G. Thieme Verlag, Stuttgart, Germany 85-106
6. Davis M.D., Kern T.S., and Rand L.I. In: Alberti K.G.M.M., Zimmet P., and DeFronzo R.A. (Eds). Diabetic retinopathy international textbook of diabetes mellitus (1997), John Wiley & Sons, West Sussex 1430
7. MacGregor L.C., and Matschinsky F.M. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats. J Clin Invest 76 (1985) 887-889
8. Lee T.S., Saltsman K.A., Ohashi H., et al. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A 86 (1989) 5141-5145
9. Kowluru R.A., Jirousek M.R., Stramm L., et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes 47 3 (1998) 464-469
10. Mamputu J.C., and Renier G. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol 75 6 (2004) 1062-1069
11. Mohr S. Potential new strategies to prevent the development of diabeticretinopathy. Exp Opin Invest Drugs 13 3 (2004) 189-198
12. Engerman R.L., and Kern T.S. Is diabetic retinopathy preventable?. Int Ophthalmol Clin 27 4 (1987) 225-229
13. Engerman R.L., and Kern T.S. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33 1 (1984) 97-100
14. Engerman R.L., Kern T.S., and Garment M.B. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. J Diabetes Complications 7 4 (1993) 241-245
15. Haefliger I.O., Zschauer A., and Anderson D.R. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest Ophthalmol Vis Sci 35 (1994) 991-997
16. Inoguchi T., Battan R., Handler E., et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89 (1992) 11059-11063
17. McCarty M.F. Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy-preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline. Med Hypotheses 50 (1998) 435-449
18. Stevens M.J., Dananberg J., Feldman E.L., et al. The linked roles of nitric oxide, aldose reductase and, (Na+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 94 (1994) 853-859
19. Marumo T., Noll T., Schini-Kerth V.B., et al. Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J Vasc Res 36 (1999) 510-515
20. Chakravarthy U., Hayes R.G., Stitt A.W., et al. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation endproducts. Diabetes 47 (1998) 945-952
21. Su E.N., Yu D.Y., Alder V.A., et al. Direct vasodilatory effect of insulin on isolated retinal arterioles. Invest Ophthalmol Vis Sci 37 (1996) 2634-2644
22. Schmetterer L., Muller M., Fasching P., et al. Renal and ocular hemodynamic effects of insulin. Diabetes 46 (1997) 1868-1874
23. Naeser P. Insulin receptors in human ocular tissues. Immunohistochemical demonstration in normal and diabetic eyes. Ups J Med Sci 102 (1997) 35-40
24. Haskell J.F., Meezan E., and Pillion D.J. Identification and characterization of the insulin receptor of bovine retinal microvessels. Endocrinology 115 (1984) 698-704
25. Folli F., Bonfanti L., Renard E., et al. Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 14 11 Pt 1 (1994) 6412-6422
26. Reiter C.E., Sandirasegarane L., Wolpert E.B., et al. Characterization of insulin signalling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab 285 4 (2003) E763-E774
27. Koevary S.B., Nussey J., and Lake S. Topically applied porcine insulin accumulates in the retina in normal and diabetic rats. Invest Ophthalmol Vis Sci 43 3 (2001) 797-804
28. Koevary S.B. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of posterior segment diseases and beyond. Curr Drug Metab 4 (2003) 151-170
29. Kowluru R., Tang J., and Kern T.S. Abnormalities of retinal metabolism in diabetes and galactosemia. VII. Effects of long-term administration of antioxidants on retinal oxidative stress and the development of retinopathy. Diabetes 50 (2001) 1938-1942
30. Kern T.S., and Engerman R.L. Pharmacologic inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Diabetes 50 (2001) 1636-1642
31. Kern T.S., Tang J., Mizutani M., et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 41 (2000) 3972-3978
32. De Juan J.A., Moya F.J., Ripodas A., et al. Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia 43 6 (2000) 773-785
33. Deng D., Evans T., Mukherjee K., et al. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia 42 10 (1999) 1228-1234
34. Klein R., Klein B.E., and Moss S.E. The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab Rev 5 7 (1989) 559-570
35. Lu M., Amano S., Miyamoto K., et al. Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci 40 (1999) 3281-3286
36. Poulaki V., Qin W., Joussen A.M., et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest 109 6 (2002) 805-815
37. Shweiki D., Neeman M., Itkin A., et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 92 (1995) 768-772
38. Li W., Liu X., He Z., et al. Expression of apoptosis regulatory genes by retinal pericytes after rapid glucose reduction. Invest Ophthalmol Vis Sci 39 (1998) 1535-1543
39. Okamoto T., Koevary S.B., and Roy S. Effect of topically-applied insulin on vascular changes in retinas of diabetic rats. Invest Ophthalmol Vis Sci (2004) ARVO abstract #3254